Literature DB >> 31167904

Gut Microbiota and Colonization Resistance against Bacterial Enteric Infection.

Q R Ducarmon1,2, R D Zwittink3,2, B V H Hornung3,2, W van Schaik4, V B Young5,6, E J Kuijper3,2,7,8.   

Abstract

The gut microbiome is critical in providing resistance against colonization by exogenous microorganisms. The mechanisms via which the gut microbiota provide colonization resistance (CR) have not been fully elucidated, but they include secretion of antimicrobial products, nutrient competition, support of gut barrier integrity, and bacteriophage deployment. However, bacterial enteric infections are an important cause of disease globally, indicating that microbiota-mediated CR can be disturbed and become ineffective. Changes in microbiota composition, and potential subsequent disruption of CR, can be caused by various drugs, such as antibiotics, proton pump inhibitors, antidiabetics, and antipsychotics, thereby providing opportunities for exogenous pathogens to colonize the gut and ultimately cause infection. In addition, the most prevalent bacterial enteropathogens, including Clostridioides difficile, Salmonella enterica serovar Typhimurium, enterohemorrhagic Escherichia coli, Shigella flexneri, Campylobacter jejuni, Vibrio cholerae, Yersinia enterocolitica, and Listeria monocytogenes, can employ a wide array of mechanisms to overcome colonization resistance. This review aims to summarize current knowledge on how the gut microbiota can mediate colonization resistance against bacterial enteric infection and on how bacterial enteropathogens can overcome this resistance.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  bacterial enteric infection; bacteriocins; bacteriophages; bile acids; colonization resistance; enteric pathogens; gut microbiota; microbiome; mucus layer; nutrient competition; short-chain fatty acids

Mesh:

Substances:

Year:  2019        PMID: 31167904      PMCID: PMC6710460          DOI: 10.1128/MMBR.00007-19

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   11.056


  280 in total

1.  The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo.

Authors:  C Atuma; V Strugala; A Allen; L Holm
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-05       Impact factor: 4.052

2.  Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.

Authors:  I Wiedemann; E Breukink; C van Kraaij; O P Kuipers; G Bierbaum; B de Kruijff; H G Sahl
Journal:  J Biol Chem       Date:  2000-10-18       Impact factor: 5.157

Review 3.  The continuing importance of bile acids in liver and intestinal disease.

Authors:  A F Hofmann
Journal:  Arch Intern Med       Date:  1999 Dec 13-27

4.  Motility as a virulence factor for Vibrio cholerae.

Authors:  M N Guentzel; L J Berry
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

5.  PhoP-PhoQ-regulated loci are required for enhanced bile resistance in Salmonella spp.

Authors:  J C van Velkinburgh; J S Gunn
Journal:  Infect Immun       Date:  1999-04       Impact factor: 3.441

6.  Isolation and characterization of cholic acid 7alpha-dehydroxylating fecal bacteria from cholesterol gallstone patients.

Authors:  J E Wells; F Berr; L A Thomas; R H Dowling; P B Hylemon
Journal:  J Hepatol       Date:  2000-01       Impact factor: 25.083

7.  The virulence regulatory protein ToxR mediates enhanced bile resistance in Vibrio cholerae and other pathogenic Vibrio species.

Authors:  D Provenzano; D A Schuhmacher; J L Barker; K E Klose
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

8.  Resistance of Escherichia coli and Salmonella against nisin and curvacin A.

Authors:  M G Gänzle; C Hertel; W P Hammes
Journal:  Int J Food Microbiol       Date:  1999-04-01       Impact factor: 5.277

9.  Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator.

Authors:  D Islam; L Bandholtz; J Nilsson; H Wigzell; B Christensson; B Agerberth; G Gudmundsson
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

10.  Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.

Authors:  K L Kotloff; J P Winickoff; B Ivanoff; J D Clemens; D L Swerdlow; P J Sansonetti; G K Adak; M M Levine
Journal:  Bull World Health Organ       Date:  1999       Impact factor: 9.408

View more
  80 in total

1.  Gut microbes regroup to aid defence after infection.

Authors:  Melissa M Kendall; Vanessa Sperandio
Journal:  Nature       Date:  2021-04       Impact factor: 49.962

2.  Refocusing Human Microbiota Research in Infectious and Immune-mediated Diseases: Advancing to the Next Stage.

Authors:  Maria Y Giovanni; Johanna S Schneider; Thomas Calder; Anthony S Fauci
Journal:  J Infect Dis       Date:  2021-07-02       Impact factor: 5.226

3.  Complex Microbiota in Laboratory Rodents: Management Considerations.

Authors:  Craig L Franklin; Aaron C Ericsson
Journal:  ILAR J       Date:  2020-10-19

4.  Siderophore piracy enhances Vibrio cholerae environmental survival and pathogenesis.

Authors:  Hyuntae Byun; I-Ji Jung; Jiandong Chen; Jessie Larios Valencia; Jay Zhu
Journal:  Microbiology (Reading)       Date:  2020-10-05       Impact factor: 2.777

Review 5.  The microbiome-shaping roles of bacteriocins.

Authors:  Simon Heilbronner; Bernhard Krismer; Heike Brötz-Oesterhelt; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2021-06-01       Impact factor: 60.633

6.  Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi.

Authors:  Mairead K Heavey; Aaron C Anselmo
Journal:  AAPS J       Date:  2021-05-19       Impact factor: 4.009

7.  Gut microbes regroup to aid defence after infection.

Authors:  Melissa M Kendall; Vanessa Sperandio
Journal:  Nature       Date:  2021-04       Impact factor: 49.962

8.  Gut Phage Database: phage mining in the cave of wonders.

Authors:  Magdalena Unterer; Mohammadali Khan Mirzaei; Li Deng
Journal:  Signal Transduct Target Ther       Date:  2021-05-17

Review 9.  Salmonella versus the Microbiome.

Authors:  Andrew W L Rogers; Renée M Tsolis; Andreas J Bäumler
Journal:  Microbiol Mol Biol Rev       Date:  2020-12-23       Impact factor: 11.056

Review 10.  Gut microbiota in Celiac Disease: microbes, metabolites, pathways and therapeutics.

Authors:  Katherine L Olshan; Maureen M Leonard; Gloria Serena; Ali R Zomorrodi; Alessio Fasano
Journal:  Expert Rev Clin Immunol       Date:  2020-12-27       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.